Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

epoetin alfa

epoetin alfa
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Epogen, Procrit SOLUTION, INJECTABLE 2,000 units/mL, 3,000 units/mL, 4,000 units/mL    
Retacrit SOLUTION, INJECTABLE 2,000 units/mL, 3,000 units/mL, 4,000 units/mL    
Epogen, Procrit SOLUTION, INJECTABLE 10,000 units/mL, 20,000 units/mL, 40,000 units/mL    
Retacrit SOLUTION, INJECTABLE 10,000 units/mL, 20,000 units/mL, 40,000 units/mL    
VIEW MORE Hematopoietic Agents
CLASS
201600
Comments:

 

 

Retacrit is the preferred agent for inpatient use.

 

Dose Rounding (Adult): epoetin alfa doses should be rounded to the nearest multiple of 2,000 unit.  Dosages on odd thousand unit increments should be rounded up (e.g. 7,000 units rounds to 8,000 units).

Management of Unattached Dialysis Outpatients: Epoetin alfa Algorithm

 

Dose Rounding (Pediatrics): epoetin alfa doses should be round to the nearest multiple of 10 unit.

 

Retacrit is a biosimilar classified as therapeutically equivalent to the epoetin alfa reference product (Epogen, Procrit) for adult and pediatric patients.

The most cost effective drug for the specific setting, time period, or patient case will be used.

Pediatrics - St. Jude has evaluated and approved RETACRIT as a  formulary agent as of October 11, 2018.

 

Epogen medication guide

Procrit medicaiton guide

Retacrit medication guide

Retacrit Dose Dispense                        *Dose available in dialysis pyxis
2,000 units One 2,000 units/mL vial*
4,000 units One 4,000 units/mL vial*
6,000 units One 4,000 units/mL vial + one 2,000 units/mL vial*
8,000 units Two 4,000 units/mL vials*
10,000 units One 10,000 units/mL vial*
12,000 units One 10,000 units/mL vial + one 2,000 units/mL vial*
14,000 units One 10,000 units/mL vial + one 4,000 units/mL vial*
16,000 units IV: One 10,000 units/mL vial + one 4,000 units/mL vial + one 2,000 units/mL vial*
Subcutaneous: PREPARE syringe using 40,000 units/mL vial
18,000 units IV: One 10,000 units/mL vial + two 4,000 units/mL vial*
Subcutaneous: PREPARE syringe using 40,000 units/mL vial
20,000 units Two 10,000 units/mL vials*
>22,000 units to 38,000 units PREPARE syringe using 40,000 unit/mL vial
40,000 units One 40,000 units/mL vial

 

Reviewed: December 12, 2006, and 28 Aug 2018 (Retacrit)

Last updated: Oct. 16, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved